Literature DB >> 17322214

Prescribing oral chemotherapy.

Sandeep D Parsad, Mark J Ratain.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17322214      PMCID： PMC1804145          DOI： 10.1136/bmj.39128.449317.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  13 in total

1.  Dear doctor: we really are not sure what dose of capecitabine you should prescribe for your patient.

Authors:  Mark J Ratain
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

2.  ASHP guidelines on preventing medication errors with antineoplastic agents.

Authors: 
Journal:  Am J Health Syst Pharm       Date:  2002-09-01       Impact factor: 2.637

3.  Oral chemotherapy safety practices at US cancer centres: questionnaire survey.

Authors:  Saul N Weingart; Jonathan Flug; Daniela Brouillard; Laurinda Morway; Ann Partridge; Sylvia Bartel; Lawrence N Shulman; Maureen Connor
Journal:  BMJ       Date:  2007-01-12

4.  Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001.

Authors:  Sharyn D Baker; Jaap Verweij; Eric K Rowinsky; Ross C Donehower; Jan H M Schellens; Louise B Grochow; Alex Sparreboom
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

5.  Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains.

Authors:  Richard B Womer; Ellen Tracy; Winson Soo-Hoo; Betsy Bickert; Susan DiTaranto; Jane H Barnsteiner
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

Review 6.  Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer.

Authors:  J Andrew Skirvin; Stuart M Lichtman
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  Patient preferences for oral versus intravenous palliative chemotherapy.

Authors:  G Liu; E Franssen; M I Fitch; E Warner
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

8.  Improving the cancer chemotherapy use process.

Authors:  D S Fischer; S Alfano; M T Knobf; C Donovan; N Beaulieu
Journal:  J Clin Oncol       Date:  1996-12       Impact factor: 44.544

Review 9.  Safe administration of oral chemotherapy.

Authors:  Ann Birner
Journal:  Clin J Oncol Nurs       Date:  2003 Mar-Apr       Impact factor: 1.027

10.  Getting the right dose in cancer chemotherapy--time to stop using surface area?

Authors:  D R Newell
Journal:  Br J Cancer       Date:  2002-04-22       Impact factor: 7.640
View more
  5 in total

1.  Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products.

Authors:  Soonmo Peter Kang; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2010-08-24       Impact factor: 12.531

2.  Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care.

Authors:  Sven Simons; Susanne Ringsdorf; Michael Braun; Ulrich J Mey; Peter F Schwindt; Yon D Ko; Ingo Schmidt-Wolf; Walther Kuhn; Ulrich Jaehde
Journal:  Support Care Cancer       Date:  2010-06-16       Impact factor: 3.603

3.  Comparison of toxicity and effectiveness between fixed-dose and body surface area-based dose capecitabine.

Authors:  Femke M de Man; G D Marijn Veerman; Esther Oomen-de Hoop; Maarten J Deenen; Didier Meulendijks; Caroline M P W Mandigers; Marcel Soesan; Jan H M Schellens; Esther van Meerten; Teun van Gelder; Ron H J Mathijssen
Journal:  Ther Adv Med Oncol       Date:  2019-04-15       Impact factor: 8.168

4.  Medication Experience and Adherence to Oral Chemotherapy: A Qualitative Study of Patients' and Health Professionals' Perspectives.

Authors:  Amparo Talens; Mercedes Guilabert; Blanca Lumbreras; María Teresa Aznar; Elsa López-Pintor
Journal:  Int J Environ Res Public Health       Date:  2021-04-17       Impact factor: 3.390

5.  Adherence management for patients with cancer taking capecitabine: a prospective two-arm cohort study.

Authors:  Linda Krolop; Yon-Dschun Ko; Peter Florian Schwindt; Claudia Schumacher; Rolf Fimmers; Ulrich Jaehde
Journal:  BMJ Open       Date:  2013-07-19       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.